Moneycontrol
HomeNewsTrendsEntertainmentCOVID-19 impact: Delhi's cinema closure a concern, to spell bad news for PVR, INOX
Trending Topics

COVID-19 impact: Delhi's cinema closure a concern, to spell bad news for PVR, INOX

Closure of theatres in Delhi will not only impact the box office collections of 83 but will also delay the upcoming movie release pipeline.

December 28, 2021 / 18:56 IST
Story continues below Advertisement
Down south, 70-year old Lakshmi Theatre and Shree Nagaraja theatre in Mysuru have been added to the list of theatres that are winding up operations. (Representative image)

New Delhi Chief Minister Arvind Kejriwal announced a yellow alert on Tuesday and ordered closure of cinema halls in the city.

The shutdown of theatres in Delhi will spell bad news for the big screen business with the market being a significant contributor to film releases especially Hindi films.

Story continues below Advertisement

"Delhi government’s decision to shut down cinemas in Delhi while enforcing the ‘yellow’ alert of the Graded Response Action Plan (GRAP) has caused massive uncertainty and could lead to irreparable damage for the Indian film industry," said Kamal Gianchandani, President, Multiplex Association of India and CEO of PVR Pictures.
He said that while they fully understand the need at government’s end to take necessary preventive measures, they request that cinemas should get equal treatment with comparable industries and institutions.

"Instead of closing the cinemas, we would urge the Delhi government to consider introducing double vaccination requirement to enter cinemas, as is the case in some of the other states including Maharashtra. Alternatively, the seating capacity restriction of 50% can be reintroduced at cinemas," he added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show